1. Age ≥ 18, both male and female;

2. Patients with primary pancreatic tumor diagnosed by histology, cytology or imaging;

3. Clinical or pathological staging is locally advanced or metastatic pancreatic tumor (newly diagnosed or after surgery and other treatments);

4. You can accept or have not received surgery, chemotherapy, radiotherapy, local treatment or traditional Chinese medicine for tumors;

5. The subject voluntarily joined the study and signed an informed consent form voluntarily.

Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center